Spikevax booster and delayed urticaria: a Swiss signal with diagnostic uncertainties due to a high proportion of direct patient reports

Eur J Clin Pharmacol. 2022 Dec;78(12):2021-2022. doi: 10.1007/s00228-022-03404-0. Epub 2022 Oct 18.

Authors

Roberta Noseda¹, Laura Müller¹, Thomas Stammschulte², Raffaela Bertoli¹, Alessandro Ceschi³

Affiliations

¹ Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Via Tesserete 46, 6900, Lugano, Switzerland.
² Pharmacovigilance Unit, Swissmedic, Bern, Switzerland.
³ Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Via Tesserete 46, 6900, Lugano, Switzerland. [email protected].

No abstract available

Publication types

Letter

MeSH terms

Humans
Switzerland
Time Factors
Urticaria* / diagnosis